Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 3704150, 7 pages
http://dx.doi.org/10.1155/2016/3704150
Research Article

Fecal Colonization with Extended-Spectrum Beta-Lactamase and AmpC-Producing Escherichia coli

1Department of Pharmaceutics, Microbiology Division, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
2Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt
3Microbiology and Immunology Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt
4College of Medicine, Alfaisal University, Riyadh, Saudi Arabia

Received 18 December 2015; Accepted 10 May 2016

Academic Editor: Wejdene Mansour

Copyright © 2016 Mohamed H. Al-Agamy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bhargava, K. Hayakawa, E. Silverman et al., “Risk factors for colonization due to carbapenem-resistant enterobacteriaceae among patients exposed to long-term acute care and acute care facilities,” Infection Control and Hospital Epidemiology, vol. 35, no. 4, pp. 398–405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. P.-L. Woerther, C. Burdet, E. Chachaty, and A. Andremont, “Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M,” Clinical Microbiology Reviews, vol. 26, no. 4, pp. 744–758, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Karah, B. Haldorsen, N. O. Hermansen et al., “Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway,” Journal of Medical Microbiology, vol. 60, no. 4, pp. 515–521, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Yezli, A. M. Shibl, and Z. A. Memish, “The molecular basis of β-lactamase production in Gram-negative bacteria from Saudi Arabia,” Journal of Medical Microbiology, vol. 64, no. 2, pp. 127–136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Guzmán-Blanco, J. A. Labarca, M. V. Villegas, and E. Gotuzzo, “Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America,” Brazilian Journal of Infectious Diseases, vol. 18, no. 4, pp. 421–433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Pfeifer, A. Cullik, and W. Witte, “Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens,” International Journal of Medical Microbiology, vol. 300, no. 6, pp. 371–379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Cantón and T. M. Coque, “The CTX-M beta-lactamase pandemic,” Current Opinion in Microbiology, vol. 9, no. 5, pp. 466–475, 2006. View at Publisher · View at Google Scholar
  8. C. Dallenne, A. da Costa, D. Decré, C. Favier, and G. Arlet, “Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 3, pp. 490–495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Clinical and Laboratory Standards Institute (CLSI), “Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement performance standards for antimicrobial susceptibility testing,” Document M100-24, Clinical and Laboratory Standards Institute (CLSI), Wayne, Pa, USA, 2014. View at Google Scholar
  10. J. A. Severin, E. S. Lestari, W. Kloezen et al., “Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002,” Tropical Medicine and International Health, vol. 17, no. 4, pp. 455–461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Li, J.-Y. Sun, Q.-Z. Liu, L.-Z. Han, X.-H. Huang, and Y.-X. Ni, “High prevalence of CTX-M β-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou, China,” Scandinavian Journal of Infectious Diseases, vol. 43, no. 3, pp. 170–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. G. V. Sanchez, R. N. Master, J. A. Karlowsky, and J. M. Bordon, “In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 4, pp. 2181–2183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. H. Bassyouni, S. N. Gaber, and A. A. Wegdan, “Fecal carriage of extended-spectrum β-lactamase- and AmpC- producing Escherichia coli among healthcare workers,” Journal of Infection in Developing Countries, vol. 9, no. 3, pp. 304–308, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Mathai, V. A. Kumar, B. Paul et al., “Fecal carriage rates of extended-spectrum β-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers,” Microbial Drug Resistance, vol. 21, no. 1, pp. 59–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. B. Jørgensen, Ø. Samuelsen, A. Sundsfjord et al., “High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae in Norwegian patients with gastroenteritis,” Scandinavian Journal of Infectious Diseases, vol. 46, no. 6, pp. 462–465, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. N. O. Yilmaz, N. Agus, E. Bozcal, O. Oner, and A. Uzel, “Detection of plasmid-mediated AmpC β-lactamase in E. coli and K. pneumoniae,” Indian Journal of Medical Microbiology, vol. 31, no. 1, pp. 53–59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. T. M. H. Bui, I. Hirai, S. Ueda et al., “Carriage of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in healthy Vietnamese individuals,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 10, pp. 6611–6614, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. S. F. Ahmed, M. M. M. Ali, Z. K. Mohamed, T. A. Moussa, and J. D. Klena, “Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community,” Annals of Clinical Microbiology and Antimicrobials, vol. 13, article 22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. J. Ko, H.-W. Moon, M. Hur, C.-M. Park, S. E. Cho, and Y.-M. Yun, “Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in Korean community and hospital settings,” Infection, vol. 41, no. 1, pp. 9–13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. E. Villar, M. N. Baserni, and M. B. Jugo, “Faecal carriage of ESBL-producing enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings,” Journal of Infection in Developing Countries, vol. 7, no. 8, pp. 630–634, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. H. Al-Agamy, M. S. Ali, M. M. Salem, and T. R. Mohamed, “Faecal colonization by extended-spectrum beta-lactamase-producing Escherichia coli from hospitalized patients,” New Egyptian Journal of Microbiology, vol. 19, pp. 285–314, 2008. View at Google Scholar
  22. J. Kaarme, Y. Molin, B. Olsen, and Å. Melhus, “Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children,” Acta Paediatrica, vol. 102, no. 6, pp. 655–660, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Hammerum, C. H. Lester, L. Jakobsen, and L. J. Porsbo, “Faecal carriage of extended-spectrum β-lactamase-producing and AmpC β-lactamase-producing bacteria among Danish army recruits,” Clinical Microbiology and Infection, vol. 17, no. 4, pp. 566–568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. A. Kader, A. Kumar, and K. A. Kamath, “Fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals,” Infection Control and Hospital Epidemiology, vol. 28, no. 9, pp. 1114–1116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Garrido, C. Seral, M. J. Gude et al., “Characterization of plasmid-mediated β-lactamases in fecal colonizing patients in the hospital and community setting in Spain,” Microbial Drug Resistance, vol. 20, no. 4, pp. 301–304, 2014. View at Publisher · View at Google Scholar · View at Scopus